Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effects of Kinect-Based Exergaming Versus Wii Fit Training on Balance and Fall Risk Among Healthy Older Adults

24 de julio de 2026 actualizado por: Foundation University Islamabad

Study, titled Effects of Kinect-Based Exergaming versus Wii Fit on Balance and Fall Risk among Healthy Older Adults, is a randomized controlled trial comparing the balance training effects of Xbox Kinect and Wii Fit.

After obtaining informed consent, 46 healthy older adults will be randomly allocated (1:1) using sealed envelopes to a 6-week training program in either group. Static, Dynamic, and Anticipatory balance will be assessed at baseline and post-intervention using the Biodex Balance System for objective comparison.

Descripción general del estudio

Descripción detallada

Balance is a complex, multidimensional concept related to postural control, referring essentially to the ability to maintain a stable posture. Each year, an estimated 37.3 million individuals experience a fall that requires hospitalization and may lead to severe injuries, such as fractures and traumatic brain injuries. Traditional balance exercises reduce fall risk but may have low long-term adherence in seniors. The introduction of VR-based games engages participants in interactive balance exercises.

The objective of this study is to evaluate the effects of Kinect-based exergaming compared to Wii Fit balance training on reducing fall risk in elderly individuals, focusing on parameters of Fall incidence, as well as Static, Dynamic, and Anticipatory balance.

The study will be a non-blinded Randomized Controlled Trial (RCT), consisting of 2 groups. The Study will be conducted over 1 year at the Multidisciplinary Development Lab (MDL) of the Foundation University College of Physical Therapy (FUCP).

A calculated sample of 46 subjects will be selected via a non-probability convenience sampling technique, followed by randomization in a 1:1 ratio to Group A (Kinect-based exergaming) or Group B (Wii Fit) using the sealed-envelope method.

After CBRC registration, ethical approval will be obtained from the Ethical Review Commitee (ERC) of Foundation University Medical College (FUMC).

Individuals fulfilling the inclusion criteria will be selected, followed by written informed consent after explaining the study purpose. Participants will then be randomly allocated to one of the 2 groups.

At baseline, investigators will assess postural control using the Postural Stability System and balance confidence using the Falls Efficacy Scale. Objective static and dynamic balance will be evaluated using the Berg Balance Scale, while cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA).

One group will be provided with Kinect-based exer-gaming balance training. The second group will be provided with the Wii Fit Balance Training. Exercise training would be performed over a 6-week intervention period, administering exercise training 3 days per week. All outcome measurements would be performed before and after the 6-week intervention period. Data will be entered and analyzed on SPSS v. 22.

Tipo de estudio

Intervencionista

Inscripción (Actual)

46

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Punjab Province
      • Islamabad, Punjab Province, Pakistán, 44000
        • Foundation University College of Physical Therapy

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Older adults aged ≥55, community-dwelling, with a BBS score between 21-50, including both mild to moderate Risk falls
  • Able to stand without assistive devices
  • Cognitively able to follow instructions, with a MoCA score ≥ 22
  • Both Genders: Males and females

Exclusion Criteria:

  • History of Neurological disorders affecting balance (e.g., Parkinson's disease, stroke)
  • Acute Vestibular disorders/Major Musculoskeletal impairments (e.g., Arthritis)
  • Participation in other balance training programs within the past 6 months
  • Any condition posing a safety risk (e.g., severe osteoporosis, uncontrolled hypertension

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Group A

Participants in this group will engage in four interactive mini-games from the Kinect Adventures collection, specifically selected for their dynamic full-body demands:

Games will be

  1. 20,000 leaks
  2. Reflex ridge
  3. River rush and
  4. Rally ball The total duration of the intervention protocol is 6 weeks. However, progression depends on the participant's comfort, performance, and adaptation to the training tasks. Training sessions will be done 3 days a week for 40-50 minutes/day

The total duration of the intervention protocol is 6 weeks. However, progression depends on the participant's comfort, performance, and adaptation to the training tasks. Training sessions will be done 3 days a week for 40- 50 minutes/day (18). Group 1 will receive Kinect-based exergaming balance training. Warm-up exercise will be for 5 minutes, including gentle stretching exercises, and 5 minutes will be given for a cool down, including deep breathing exercises

Group (A) / (Kinect-based Exergaming balance training):

  1. 20,000 leaks
  2. Reflex ridge
  3. River rush
  4. Rally ball
Experimental: Group B

Participants in this group will engage in four interactive games , specifically selected for their dynamic full-body demands.These games collectively target key balance components,static control, dynamic adjustment, and anticipatory balance Games will be

  1. Lotus focus
  2. Soccer header,
  3. Tight rope walk and
  4. Ski slalom. The total duration of the intervention protocol is 6 weeks. However, progression depends on the participant's comfort, performance, and adaptation to the training tasks. Training sessions will be done 3 days a week for 40-50 minutes/day.

The total duration of the intervention protocol is 6 weeks. However, progression depends on the participant's comfort, performance, and adaptation to the training tasks. Training sessions will be done 3 days a week for 40- 50 minutes/day (18). Group 2 will receive Wii Fit balance training. Warm-up exercise will be for 5 minutes, including gentle stretching exercises, and 5 minutes will be given for a cool down, including deep breathing exercises

Group (B) / Wii Fit balance training:

  1. Soccer header
  2. Lotus Focus(Minimal)
  3. Tightrope Walk
  4. Ski slalom

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Postural stability
Periodo de tiempo: 6 weeks.

Static postural stability will be assessed using the Biodex Balance System SD at stability level 12. The Overall Stability Index (OSI) measures the variance of platform displacement during static standing. The Overall Stability Index (OSI) is expressed in degrees. Lower OSI values indicate better postural stability and reduced postural sway, whereas higher values indicate impaired balance control.

Assessment will be performed at baseline and after 6 weeks of intervention. Intervention will be conducted 3 sessions per week for 6 weeks, with each session lasting 30-45 minutes

6 weeks.
Balance
Periodo de tiempo: 6 weeks
Berg Balance scale will be used. 5-point ordinal scale (graded 0-4), Max score = 56 41-56 = low fall risk, 21-40 = medium fall risk, 0 -20 = high fall risk R=0.88-0.98.
6 weeks
Concern of Fall
Periodo de tiempo: 6 weeks

Fall Efficacy Scale will be used. 16 items Questionnaire. Individuals are instructed to score their concern of falling during an activity. Performed at the start of the treatment protocol, and after 8 weeks at the end of the intervention

1 as not concerned at all and 4 as very concerned. The item scores are summed up to obtain a total of 64. 16 = no concern about falling, > 16 = concern about falling

6 weeks
Cognition
Periodo de tiempo: 6 weeks

Montreal Cognitive Assessment (MoCA) A 30-item global cognitive screening tool scored from 0-30. Higher scores indicate better cognition.

26-30: Normal cognition 18-25: Mild cognitive impairment (MCI) 10-17: Moderate cognitive impairment

≤ 9: Severe cognitive impairment One extra point is added for individuals with ≤12 years of formal education to adjust for educational bias

6 weeks
Dynamic balance
Periodo de tiempo: 6 weeks

Dynamic balance will be assessed using the Biodex Balance System SD at stability level 6 under unstable surface conditions. Balance performance will be quantified using the Overall Stability Index (OSI). The Overall Stability Index (OSI) is expressed in degrees.Lower OSI scores represent improved dynamic balance and neuromuscular control, whereas higher values indicate poorer balance performance.

Assessment will be performed at baseline and after 6 weeks of intervention. Intervention will be conducted 3 sessions per week for 6 weeks, with each session lasting 30-45 minutes

6 weeks
Limits of Stability
Periodo de tiempo: 6 weeks

Limits of Stability testing will be used to assess the participant's ability to intentionally displace the center of pressure toward visual targets without losing balance. Higher LOS scores indicate better anticipatory postural control and balance performance, whereas lower scores indicate impaired balance ability.

Assessment will be performed at baseline and after 6 weeks of intervention. Intervention will be conducted 3 sessions per week for 6 weeks, with each session lasting 30-45 minutes

6 weeks
Fall Risk Index
Periodo de tiempo: 6 week

The Fall Risk Test using the Biodex Balance System will assess the participant's risk of falls under progressively unstable conditions. Higher Fall Risk Index scores indicate greater fall risk and poorer balance ability, whereas lower scores indicate improved balance and reduced fall risk.

Assessment will be performed at baseline and after 6 weeks of intervention.

6 week

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Nayab Khan, DPT, Foundation University Islamabad

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

5 de mayo de 2026

Finalización primaria (Actual)

1 de julio de 2026

Finalización del estudio (Actual)

15 de julio de 2026

Fechas de registro del estudio

Enviado por primera vez

4 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

12 de mayo de 2026

Publicado por primera vez (Actual)

19 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

27 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

24 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • FUI/FUCP/CTR/Neuro2/Nayyab

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir